Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Giant Biogene Holding Co. Ltd. ( (HK:2367) ) is now available.
Giant Biogene Holding Co., Ltd announced an increase in shareholding by its controlling shareholder, Juzi Holding Co., Ltd, as a demonstration of confidence in the company’s future development. Juzi Holding has purchased 2,006,600 shares, amounting to approximately HK$105.6 million, raising its total ownership to 54.45% of the company’s issued shares. This move is intended to promote sustainable growth and protect public investor interests, with potential further share purchases depending on market conditions.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$70.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, focusing on the biotechnology industry. It is primarily involved in the development and commercialization of biotechnological products and services.
Average Trading Volume: 11,637,344
Technical Sentiment Signal: Buy
Current Market Cap: HK$66.84B
See more insights into 2367 stock on TipRanks’ Stock Analysis page.